Shares of Verici Dx plc (LON:VRCI – Get Free Report) passed above its 50 day moving average during trading on Monday. The stock has a 50 day moving average of GBX 0.22 and traded as high as GBX 0.25. Verici Dx shares last traded at GBX 0.23, with a volume of 4,485,057 shares traded.
Verici Dx Stock Down 0.9%
The business has a 50-day moving average of GBX 0.22 and a 200 day moving average of GBX 0.40. The company has a market capitalization of £5.22 million, a PE ratio of 2.28 and a beta of 1.22. The company has a debt-to-equity ratio of 13.51, a current ratio of 2.82 and a quick ratio of 8.49.
Verici Dx Company Profile
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
Featured Stories
- Five stocks we like better than Verici Dx
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
